塞力医疗 - Financials

塞力医疗 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
+Revenue	1.8B	2.0B	2.3B	2.6B	2.1B	1.8B	1.3B	921.0M	627.0M	530.0M	445.0M	392.0M	283.0M	194.0M
Revenue Growth %	-9.7%	-13.1%	-11.2%	22.4%	16.1%	39.0%	43.0%	46.9%	18.3%	19.1%	13.5%	38.5%	45.9%	--
Total Revenue	1.8B	2.0B	2.3B	2.6B	2.1B	1.8B	1.3B	921.0M	627.0M	530.0M	445.0M	392.0M	283.0M	194.0M
Cost Of Revenue	1.5B	1.6B	1.9B	2.1B	1.6B	1.3B	899.0M	610.0M	409.0M	342.0M	281.0M	246.0M	176.0M	111.0M
+Gross Profit	332.0M	393.0M	459.0M	548.0M	492.0M	521.0M	418.0M	311.0M	218.0M	188.0M	164.0M	146.0M	107.0M	83.0M
Gross Margin %	18.3%	19.6%	19.9%	21.1%	23.2%	28.5%	31.7%	33.8%	34.8%	35.5%	36.9%	37.2%	37.8%	42.8%
Total Operating Cost	1.9B	2.2B	2.5B	2.6B	2.0B	1.6B	1.2B	791.0M	532.0M	447.0M	369.0M	326.0M	231.0M	144.0M
Selling Expenses	128.0M	147.0M	135.0M	138.0M	114.0M	117.0M	97.3M	80.9M	50.9M	43.2M	35.7M	29.4M	22.6M	13.7M
Admin Expenses	175.0M	184.0M	209.0M	204.0M	150.0M	140.0M	103.0M	67.3M	50.2M	44.7M	39.2M	34.8M	27.9M	14.0M
Rd Expenses	46.7M	43.2M	29.4M	35.5M	19.5M	10.5M	7.5M	5.1M	--	--	--	--	--	--
Finance Expenses	55.1M	72.9M	88.3M	76.6M	48.5M	41.8M	25.4M	9.8M	8.2M	7.4M	4.1M	4.0M	1.7M	781,000
+Operating Income	-142.0M	-180.0M	-149.0M	-16.2M	117.0M	187.0M	159.0M	139.0M	94.6M	83.1M	76.1M	67.6M	52.1M	50.1M
Operating Margin %	-7.8%	-9.0%	-6.5%	-0.6%	5.5%	10.2%	12.1%	15.1%	15.1%	15.7%	17.1%	17.3%	18.4%	25.8%
Non Operating Income	1.4M	3.0M	363,600	440,400	23,800	119,100	81,000	304,800	2.4M	3.5M	3.8M	2.5M	21,000	250,700
Non Operating Expenses	7.9M	15.2M	43.6M	8.3M	8.9M	1.3M	2.3M	59,400	23,600	1.1M	3.1M	560,300	196,200	72,200
Investment Income	-65.2M	-2.4M	-6.0M	-25.7M	745,200	344,600	-630,900	1.0M	--	--	--	1.1M	--	--
Asset Disposal Income	-7.6M	-2.5M	-22,700	400,400	-157,400	-160,900	-2.7M	358,800	-294,100	--	--	--	--	--
Asset Impairment Loss	25.6M	35.5M	39.8M	2.4M	2.8M	1.4M	16.5M	12.4M	9.9M	5.0M	4.4M	7.4M	1.9M	2.7M
Other Income	2.7M	4.1M	3.1M	7.5M	5.1M	4.7M	3.1M	8.3M	--	--	--	--	--	--
Income Before Tax	-148.0M	-193.0M	-192.0M	-24.1M	108.0M	186.0M	156.0M	139.0M	96.9M	85.6M	76.9M	69.6M	51.9M	50.3M
Income Tax	45.1M	-35.7M	-1.5M	14.3M	26.0M	43.8M	40.0M	32.6M	23.4M	21.2M	19.3M	18.7M	14.7M	13.7M
+Net Income	-193.0M	-157.0M	-190.0M	-38.4M	82.0M	142.0M	116.0M	107.0M	73.5M	64.3M	57.6M	50.9M	37.2M	36.6M
Net Margin %	-10.7%	-7.8%	-8.2%	-1.5%	3.9%	7.8%	8.8%	11.6%	11.7%	12.1%	12.9%	13.0%	13.2%	18.9%
Net Income Attributable	-209.0M	-159.0M	-154.0M	-49.5M	57.6M	110.0M	94.2M	93.8M	68.9M	61.5M	56.5M	49.1M	38.3M	37.8M
Minority Interest	15.9M	1.8M	-36.5M	11.1M	24.5M	32.0M	22.3M	12.7M	4.6M	2.8M	1.1M	1.8M	-1.1M	-1.1M
Eps Basic	-1.09	-0.82	-0.79	-0.25	0.29	0.56	0.49	0.53	0.97	1.61	1.48	1.28	1.03	--
Eps Diluted	-1.09	-0.82	-0.79	-0.25	0.29	0.56	0.49	0.53	0.97	1.61	1.48	1.28	1.03	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash And Equivalents	209.0M	279.0M	395.0M	474.0M	662.0M	508.0M	703.0M	196.0M	354.0M	96.7M	66.5M	50.2M	50.9M	64.1M
Trading Financial Assets	--	--	--	12.0M	--	2.0M	--	--	--	--	--	--	--	--
Accounts Receivable	1.3B	1.5B	1.8B	1.8B	1.5B	1.1B	852.0M	577.0M	360.0M	273.0M	241.0M	184.0M	134.0M	108.0M
Notes Receivable	45.8M	39.5M	24.1M	68.7M	23.3M	--	15.7M	18.0M	25.4M	20.9M	12.2M	10.1M	2.9M	3.1M
Notes And Accounts Receivable	1.3B	1.6B	1.8B	1.8B	1.5B	1.1B	867.0M	595.0M	385.0M	294.0M	253.0M	194.0M	137.0M	112.0M
Prepayments	55.4M	71.8M	100.0M	106.0M	88.6M	76.5M	60.3M	88.3M	56.4M	32.6M	23.6M	18.5M	10.3M	24.2M
Inventory	326.0M	342.0M	421.0M	464.0M	402.0M	349.0M	274.0M	202.0M	76.1M	66.0M	55.9M	60.9M	91.7M	42.1M
Total Current Assets	2.1B	2.4B	3.0B	3.2B	2.9B	2.2B	2.0B	1.1B	890.0M	506.0M	406.0M	330.0M	297.0M	250.0M
Long Term Equity Investment	45.4M	61.7M	67.7M	183.0M	164.0M	62.4M	26.5M	--	--	--	--	--	--	--
Fixed Assets	--	156.0M	184.0M	194.0M	240.0M	236.0M	237.0M	204.0M	160.0M	123.0M	100.0M	95.0M	79.9M	53.1M
Fixed Assets Total	122.0M	156.0M	184.0M	194.0M	240.0M	236.0M	237.0M	204.0M	160.0M	123.0M	100.0M	95.0M	79.9M	53.1M
Construction In Progress	--	8.6M	3.4M	12.1M	5.8M	10.7M	2.2M	7.4M	919,300	--	--	--	--	--
Construction In Progress Total	2.2M	8.6M	3.4M	12.1M	5.8M	10.7M	2.2M	7.4M	919,300	--	--	--	--	--
Intangible Assets	33.0M	34.3M	29.8M	31.3M	32.2M	11.3M	9.0M	7.4M	7.6M	7.8M	8.0M	8.1M	8.4M	8.6M
Long Term Deferred Expenses	30.2M	24.9M	31.5M	34.0M	41.3M	46.3M	34.6M	30.6M	7.3M	2.3M	322,500	535,100	1.4M	477,300
Total Non Current Assets	743.0M	947.0M	1.0B	1.1B	978.0M	778.0M	632.0M	460.0M	203.0M	158.0M	131.0M	107.0M	92.1M	64.1M
Total Assets	2.8B	3.3B	4.0B	4.3B	3.9B	3.0B	2.6B	1.6B	1.1B	663.0M	538.0M	438.0M	389.0M	314.0M
Short Term Borrowings	423.0M	444.0M	779.0M	690.0M	695.0M	809.0M	671.0M	287.0M	141.0M	98.0M	61.0M	24.6M	20.9M	13.5M
Accounts Payable	730.0M	746.0M	720.0M	565.0M	400.0M	236.0M	99.3M	56.0M	8.5M	25.8M	19.2M	14.7M	21.6M	11.4M
Advance Receipts	--	--	--	--	--	35.0M	29.3M	18.9M	13.6M	6.4M	8.0M	6.1M	8.9M	5.4M
Contract Liabilities	35.4M	23.4M	26.8M	65.7M	32.8M	--	--	--	--	--	--	--	--	--
Total Current Liabilities	1.4B	1.4B	1.8B	1.7B	1.4B	1.3B	934.0M	532.0M	207.0M	182.0M	108.0M	70.3M	66.3M	53.3M
Long Term Borrowings	12.0M	23.7M	19.8M	273.0M	254.0M	50.0M	9.4M	28.3M	20.0M	3.8M	22.7M	19.5M	23.1M	2.2M
Total Non Current Liabilities	497.0M	632.0M	625.0M	814.0M	716.0M	65.9M	22.9M	33.2M	26.3M	10.9M	23.5M	21.5M	26.0M	7.0M
Total Liabilities	1.9B	2.0B	2.5B	2.6B	2.1B	1.4B	957.0M	566.0M	233.0M	193.0M	132.0M	91.8M	92.3M	60.3M
Paid In Capital	191.0M	202.0M	204.0M	205.0M	205.0M	205.0M	205.0M	71.3M	50.9M	38.2M	38.2M	38.2M	38.2M	36.6M
Capital Reserve	627.0M	820.0M	834.0M	854.0M	857.0M	849.0M	925.0M	471.0M	491.0M	190.0M	190.0M	190.0M	190.0M	133.0M
Surplus Reserve	45.4M	45.4M	45.3M	45.3M	37.4M	36.6M	27.3M	25.6M	21.2M	16.6M	11.8M	7.4M	3.8M	6.6M
Retained Earnings	45.0M	254.0M	411.0M	566.0M	599.0M	558.0M	451.0M	366.0M	281.0M	216.0M	160.0M	107.0M	62.0M	76.3M
Minority Equity	27.8M	104.0M	94.3M	181.0M	155.0M	132.0M	105.0M	70.4M	15.7M	9.6M	6.7M	3.2M	2.8M	1.9M
Equity Attributable	934.0M	1.2B	1.4B	1.6B	1.6B	1.5B	1.5B	933.0M	844.0M	461.0M	399.0M	343.0M	294.0M	252.0M
Total Equity	962.0M	1.3B	1.5B	1.7B	1.8B	1.6B	1.6B	1.0B	859.0M	470.0M	406.0M	346.0M	297.0M	254.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash From Sales	2.1B	2.2B	2.3B	2.5B	2.0B	1.8B	1.3B	867.0M	645.0M	579.0M	460.0M	397.0M	331.0M	220.0M
Total Operating Cash Inflow	2.2B	2.2B	2.3B	2.5B	2.0B	1.8B	1.3B	887.0M	653.0M	595.0M	464.0M	413.0M	332.0M	221.0M
Cash Paid For Goods	1.6B	1.6B	1.7B	2.1B	1.6B	1.3B	1.0B	725.0M	500.0M	392.0M	296.0M	264.0M	247.0M	192.0M
Cash Paid To Employees	201.0M	208.0M	215.0M	211.0M	160.0M	141.0M	123.0M	81.9M	50.1M	44.9M	35.2M	27.5M	16.2M	11.5M
Taxes Paid	96.8M	110.0M	151.0M	140.0M	129.0M	132.0M	123.0M	73.8M	66.8M	55.2M	55.3M	49.7M	32.1M	21.7M
Total Operating Cash Outflow	2.1B	2.1B	2.3B	2.7B	2.0B	1.8B	1.4B	950.0M	670.0M	549.0M	434.0M	380.0M	329.0M	245.0M
Operating Cash Flow	99.6M	126.0M	28.1M	-134.0M	9.9M	93.9M	-63.8M	-63.3M	-17.0M	46.1M	30.1M	32.5M	2.7M	-24.2M
Total Investing Cash Inflow	66.4M	129.0M	455.0M	135.0M	35.7M	6.8M	4.0M	591,800	--	--	42,900	2.6M	--	--
Total Investing Cash Outflow	74.1M	114.0M	295.0M	250.0M	325.0M	289.0M	233.0M	249.0M	69.0M	40.5M	49.5M	36.9M	41.5M	31.6M
Investing Cash Flow	-7.7M	15.2M	160.0M	-115.0M	-289.0M	-282.0M	-229.0M	-249.0M	-69.0M	-40.5M	-49.5M	-34.3M	-41.5M	-31.6M
Cash From Borrowings	374.0M	695.0M	890.0M	1.0B	1.5B	928.0M	718.0M	307.0M	164.0M	135.0M	76.4M	53.4M	55.6M	28.5M
Dividends And Interest Paid	59.9M	38.8M	52.3M	49.5M	59.3M	50.1M	37.2M	14.7M	7.5M	7.3M	4.2M	3.8M	2.4M	1.2M
Debt Repayments	421.0M	801.0M	1.1B	939.0M	1.4B	759.0M	363.0M	141.0M	128.0M	99.8M	42.6M	47.7M	30.9M	48.2M
Total Financing Cash Inflow	458.0M	909.0M	1.2B	1.1B	2.0B	1.0B	1.3B	318.0M	483.0M	135.0M	78.8M	56.7M	61.4M	167.0M
Total Financing Cash Outflow	606.0M	1.1B	1.6B	1.1B	1.6B	1.0B	559.0M	163.0M	140.0M	110.0M	48.1M	55.7M	35.9M	53.9M
Financing Cash Flow	-148.0M	-214.0M	-317.0M	61.4M	441.0M	4.7M	776.0M	155.0M	343.0M	24.6M	30.8M	1.1M	25.6M	113.0M
Net Change In Cash	-56.4M	-73.3M	-129.0M	-187.0M	162.0M	-184.0M	483.0M	-157.0M	257.0M	30.2M	11.3M	-751,000	-13.2M	57.0M
Ending Cash Balance	207.0M	264.0M	337.0M	466.0M	653.0M	491.0M	675.0M	191.0M	349.0M	91.7M	61.5M	50.2M	50.9M	64.1M
Capex	23.2M	40.8M	54.6M	60.2M	128.0M	96.5M	119.0M	116.0M	69.0M	40.5M	31.7M	34.3M	41.0M	28.7M